Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients

Background: Active Vitamin D analogues are used clinically for prevention and treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. Nutritional vitamin D supplementation is used for additional local parathyroid (PTH) suppression, with lower incidence of hypercalcemia and h...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients
Main Authors: Zheng, Jing-Quan, Hou, Yi-Chou, Zheng, Cai-Mei, Lu, Chien-Lin, Liu, Wen-Chih, Wu, Chia-Chao, Huang, Ming-Te, Lin, Yuh-Feng, Lu, Kuo-Cheng
Format: Artigo
Language:Inglês
Published: MDPI 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5133095/
https://ncbi.nlm.nih.gov/pubmed/27827962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu8110708
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items